101192-30-7

Basic information

• Product Name: ETHYL BENZO[6,7]-4-OXO-4H-QUINOLIZINE-3-CARBOXLATE
• Synonyms: ETHYL BENZO[6,7]-4-OXO-4H-QUINOLIZINE-3-CARBOXLATE;1-Oxo-1H-benzo[c]quinolizine-2-carboxylic Acid Ethyl Ester
• CAS NO: 101192-30-7
• Molecular Formula: C16H13NO3
• Molecular Weight: 267.28
• Product Categories: Chelating Agents, Ligands;Chelating Agents & Ligands;Fluorescent Labels & Indicators
• Mol File: 101192-30-7.mol
• Article Data: 1

Chemical Properties

• Melting Point: 106-108°C
• Boiling Point: 489.3±45.0 °C(Predicted)
• Appearance: /
• Density: 1.31±0.1 g/cm3(Predicted)
• PKA: -0.77±0.40(Predicted)
• CAS DataBase Reference: ETHYL BENZO[6,7]-4-OXO-4H-QUINOLIZINE-3-CARBOXLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL BENZO[6,7]-4-OXO-4H-QUINOLIZINE-3-CARBOXLATE(101192-30-7)
• EPA Substance Registry System: ETHYL BENZO[6,7]-4-OXO-4H-QUINOLIZINE-3-CARBOXLATE(101192-30-7)

Safety Data

• Hazardous Substances Data: 101192-30-7(Hazardous Substances Data)

Usage

Chemical Properties

Orange Crystalline Solid

Uses

Different sources of media describe the Uses of 101192-30-7 differently. You can refer to the following data:
1. A selective fluorophore which shows a strong fluorescent response to Magesium
2. A selective fluorophore which shows a strong fluorescent response to Magesium.

Relevant articles and documents

Quinolizinone compounds and pharmaceutical composition comprising the same, useful as anti-ulcerative and anti-allergic agents

The invention relates to novel quinolizinone compounds having inhibitory activity on allergies and ulcers, of the formula: STR1 wherein R1 is tetrazolylcarbamoyl; R7 is hydrogen or aryl selected from phenyl, tolyl, xylyl, cumenyl, naphthyl and biphenylyl; R2 is hydrogen, hydroxy, lower alkyl or lower alkoxy; R3 is hydrogen, hydroxy, lower alkyl, lower alkoxy, lower alkenyloxy, phenyl, napthyl, biphenylyl, phenyl having one or more substituent(s) selected from halogen, lower alkyl and lower alkoxy, arylthio selected from phenylthio, tolylthio, xylylthio, cumenylthio, naphthylthio and biphenylthio, aroyl selected from benzoyl, toluoyl and naphthoyl, ar(lower)alkyl selected from phenyl(lower)alkyl, tolyl(lower)alkyl, xylyl(lower)alkyl, cumenyl(lower)alkyl, naphthyl(lower)alkyl and biphenylyl(lower)alkyl, arenesulfonyl selected from benzenesulfonyl and p-toluenesulfonyl, arylamino selected from phenylamino, naphthylamino, biphenylylamino, phenylamino having lower alkyl on the nitrogen atom or aryloxy selected from phenoxy and tolyloxy; or pharmaceutically acceptable salts thereof.